The treatment of the cause of myocarditis in not easy from because it can be caused by an enormous number of agents, when each of them attack and damage the heart muscle in a different way. All over the world different research cardiological departments try to find causal treatment for myocarditis (treatment aimed at the agent-cause of myocarditis), which is really complicated. Some methods already exist, but they are still being studied. The effort of research departments to find a causal treatment is linked with the fact that myocarditis is considered to be the most frequent cause of dilated, respectively inflammatory cardiomyopathy, with increasing number of new patients every year. The treatment consists mostly of the treatment of potential heart failure and immunological treatment…
Myocarditis may in some cases have a dramatic course and signs of heart failure and life-threatening arrhythmias can appear. During heart failure, the heart function gets worse – heart contractility is worse than normal. Physicians try to influence this situation with standard heart failure treatment…
Antibiotics are indicated for myocarditis, when the cause of the disease is a bacterium. Very frequently it is Borrelia burgdorferi which is transferred by ticks and causes Lyme disease. Treatment is under way mostly for several weeks and antibiotics are often administered intravenously (into a vein). Some of the antibiotics in this group include cefalosporines, tetracyclines, penicillin and erythromycin. In complicated myocarditis higher doses of antibiotics are indicated. Antibiotics are indicated according to the results of a sensitivity test on discovered bacterial cause. In some cases, antibiotics are indicated as a prevention of secondary infection. Antivirotics should according to the predictions of physicians play a crucial role in the treatment of viral myocarditis, however researches have not confirmed this prediction…
This part of the treatment of myocarditis is already used in clinical practise, but it is still being researched. The mechanisms of the effect of these substances, which influence the activity of the immune system are sometimes not completely explained in the case of myocarditis and research into this topic have sometimes produced different results in a question of effectivity of these drugs in the treatment of myocarditis. It is also very important note that everyone reacts to the treatment differently (not just in case of immunological treatment). You can find news from research of these substances in category Research – subcategory News. A major part of the researches is identical in the result that the use of so called nonsteroidal anti-inflammatory drugs (indometacin, phenylbutazone, ibuprofen) is not recommended in acute phase of the disease, because it could increase the amount of fibrosis (scars) and inflammation in the heart muscle…. Researched immunological treatment in myocarditis without the presence of infectious cause are immunosuppressive therapy and corticosteroids…
The patient´s state of health, mainly in fulminant and giant cell myocarditis, may be sometimes very severe and pharmacological treatment itself is not sufficient in some situations. In such cases, physicians get provide mechanical support of the patient´s organs with the goal of improving the patient´s state of health or to “buy some time” for other treatment. This type of treatment contains several and different possibilities. It could be artificial lung ventilation and oxygenation, when the role of the lungs and the distribution of oxygen and other gases in the body is partially or completely replaced with mechanical support…